In vivo functions of the auxiliary genes and regulatory elements of feline immunodeficiency virus

Veterinary Microbiology

Volumn 60, Issue 2-4, 1998, Pages 141-153

  Inoshima, Yasuo ^a   Miyazawa, Takayuki ^a   Mikami, Takeshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

AIDS; Auxiliary genes; FIV; In vivo; Regulatory elements

Indexed keywords

ARTICLE; CAT DISEASE; FELINE IMMUNODEFICIENCY VIRUS; NONHUMAN; REGULATOR GENE; VIRUS CHARACTERIZATION; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTIVITY;

EID: 0032574121     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1135(98)00157-6     Document Type: Review

References (89)

1. Abramo F., Bo S., Canese M.G., Poli A. Regional distribution of lesions in the central nervous system of cats infected with feline immunodeficiency virus. AIDS Res. Hum. Retroviruses. 11:1995;1247-1253.
2. Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., Tozzini F. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 8:1995;87-112.
3. Bertani L.E., Häggmark A., Reichard P. Enzymatic synthesis of deoxyribonucleotides: II. Formation and interconversion of deoxyuridine phosphates. J. Biol. Chem. 238:1963;3407-3413.
4. Bosch M.L., Siebelink K.H.J., Osterhaus A.D.M.E. Genomic organization and genetic variation of feline immunodeficiency virus. AIDS Res. Rev. 3:1993;21-39.
5. Chatis P.A., Holland C.A., Hartley J.W., Rowe W.P., Hopkins N. Role of the 3′-end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc. Natl. Acad. Sci. U.S.A. 80:1983;4408-4411.
6. Chatis P.A., Holland C.A., Silver J.E., Frederickson T.N., Hopkins N., Hartley J.W. A 3′-end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus. J. Virol. 52:1984;248-254.
7. Clements J.E. Genetic regulation of the ungulate lentiviruses. AIDS. 5:1991;S15-S20. (Suppl. 2).
8. Clements J.E., Payne S.L. Molecular basis of the pathobiology of lentiviruses. Virus Res. 32:1994;97-109.
9. Clements J.E., Wong-Staal F. Molecular biology of lentiviruses. Semin. Virol. 3:1992;137-146.
10. Coffin, J.M., Essex, M., Gallo, R., Graf, T.M., Hinuma, Y., Hunter, E., Jaenisch, R., Nusse, R., Oroszlan, S., Svoboda, J., Teich, N., Toyoshima, K., Varmus, H., 1995. Retroviridae. In: Murphy, F.A., Fauquet, C.M., Bishop, D.H.L., Ghabrial, S.A., Jarvis, A.W., Martelli, G.P., Mayo, M.A., Summers, M.D. (Eds.), Virus Taxonomy, Springer-Verlag, Wien, pp. 193-204.
11. Cullen B.R. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:1992;375-394.
12. Cullen B.R., Greene W.C. Functions of the auxiliary gene products of the human immunodeficiency virus type 1. Virology. 178:1990;1-5.
13. Deacon N.J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D.J., McPhee D.A., Greenway A.L., Ellett A., Chatfield C., Lawson V.A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J.S., Cunningham A., Dwyer D., Dowton D., Mills J. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science. 270:1995;988-991.
14. Desrosiers R.C. HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res. Hum. Retroviruses. 8:1992;411-421.
15. Dow S.W., Poss M.L., Hoover E.A. Feline immunodeficiency virus: a neurotropic lentivirus. J. Acquired Immune Defic. Syndr. 3:1990;658-668.
16. Elder J.H., Phillips T.R. Molecular properties of feline immunodeficiency virus (FIV). Infect. Agents Dis. 2:1993;361-374.
17. Elder J.H., Phillips T.R. Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections. Adv. Virus Res. 45:1995;225-247.
18. Elder J.H., Lerner D.L., Hasselkus-Light C.S., Fontenot D.J., Hunter E., Luciw P.A., Montelaro R.C., Phillips T.R. Distinct subsets of retroviruses encode dUTPase. J. Virol. 66:1992;1791-1794.
19. Garvey K.J., Oberste M.S., Elser J.E., Braun M.J., Gonda M.A. Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiency-like virus. Virology. 175:1990;391-409.
20. Gibbs, J.S., Desrosiers, R.C., 1993. Auxiliary proteins of the primate immunodeficiency viruses. In: Cullen, B.R. (Ed.), Human retroviruses, Oxford Univ. Press, Oxford, pp. 137-158.
21. Greenberg G.R., Somerville R.L. Deoxyuridylate kinase activity and deoxyuridine triphosphatase in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 48:1962;247-257.
22. Hammes S.R., Dixon E.P., Malim M.H., Cullen B.R., Greene M.C. Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9549-9553.
23. Harmache A., Vitu C., Russo P., Bouyac M., Hieblot C., Peveri P., Vigne R., Suzan M. The caprine arthritis encephalitis virus tat gene is dispensable for efficient viral replication in vitro and in vivo. J. Virol. 69:1995;5445-5454.
24. Harmache A., Russo P., Guiguen F., Vitu C., Vignoni M., Bouyac M., Hieblot C., Pepin M., Vigne R., Suzan M. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology. 224:1996;246-255.
25. Harmache A., Russo P., Vitu C., Guiguen F., Mornex J.-F., Pepin M., Vigne R., Suzan M. Replication in goats in vivo of caprine arthritis-encephalitis virus deleted in vif or tat genes: possible use of these deletion mutants as live vaccines. AIDS Res. Hum. Retroviruses. 12:1996;409-411.
26. Hurtrel M., Ganière J.-P., Guelfi J.-F., Chakrabarti L., Maire M.-A., Gray F., Montagnier L., Hurtrel B. Comparison of early and late feline immunodeficiency virus encephalopathies. AIDS. 6:1992;399-406.
27. Inoshima Y., Tomonaga K., Ikeda Y., Miyazawa T., Mikami T. Quantification of feline immunodeficiency virus (FIV) proviral DNA in peripheral blood mononuclear cells of cats infected with Japanese strains of FIV. J. Vet. Med. Sci. 57:1995;487-492.
28. Inoshima Y., Ikeda Y., Kohmoto M., Pecoraro M.R., Shimojima M., Shimojima Y., Inada G., Kawaguchi Y., Tomonaga K., Miyazawa T., Mikami T. Persistence of high virus neutralizing antibody titers in cats experimentally infected with feline immunodeficiency virus. J. Vet. Med. Sci. 58:1996;925-927.
29. Inoshima Y., Kohmoto M., Ikeda Y., Yamada H., Kawaguchi Y., Tomonaga K., Miyazawa T., Kai C., Umemura T., Mikami T. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats. J. Virol. 70:1996;8518-8526.
30. Inoshima, Y., Miyazawa, T., Mikami, T., 1998. The roles of vif and ORF-A genes and AP-1 binding site in in vitro replication of feline immunodeficiency virus. Arch. Virol., in press.
31. Ishida T., Tomoda I. Clinical staging of feline immunodeficiency virus infection. Jpn. J. Vet. Sci. 52:1990;645-648.
32. Jamieson B.D., Aldrovandi G.M., Planelles V., Jowett J.B., Gao L., Bloch L.M., Chen I.S., Zack J.A. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68:1994;3478-3485.
33. Kawaguchi Y., Mikami T. Molecular interactions between retroviruses and herpesviruses. J. Vet. Med. Sci. 57:1995;801-811.
34. Kawaguchi Y., Miyazawa T., Horimoto T., Itagaki S., Fukasawa M., Takahashi E., Mikami T. Activation of feline immunodeficiency virus long terminal repeat by feline herpesvirus type 1. Virology. 184:1991;449-454.
35. Kawaguchi Y., Norimine J., Miyazawa T., Kai C., Mikami T. Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1. Virology. 190:1992;465-468.
36. Kawakami T., Sherman L., Dahlberg J., Gazit A., Yaniv A., Tronick S.R., Aaronson S.A. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology. 158:1987;300-312.
37. Kestler H.W.I., Mori K., Silva D.P., Kodama T., King N.W., Daniel M.D., Desrosiers R.C. nef genes of SIV. J. Med. Primatol. 19:1990;421-429.
38. Kestler H.W.I., Ringler D.J., Mori K., Panicali D.L., Sehgal P.K., Daniel M.D., Desrosiers R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:1991;651-662.
39. Kim S., Ikeuchi K., Byrn R., Groopman J., Baltimore D. Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9544-9548.
40. Kirchhoff F., Greenough T.C., Brettler D.B., Sullivan J.L., Desrosiers R.C. Absence of intact nef sequence in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:1995;228-232.
41. Langley R.J., Hirsch V.M., O'Brien S.J., Adger-Johnson D., Goeken R.M., Olmsted R.A. Nucleotide sequence analysis of puma lentivirus (PLV-14): genomic organization and relationship to other lentiviruses. Virology. 202:1994;853-864.
42. Lenz J., Celander D., Crowther R.L., Patarca R., Perkins D.W., Haseltine W.A. Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature. 308:1984;467-470.
43. Lerner D.L., Wagaman P.C., Phillips T.R., Prospéro-García O., Henriksen S.J., Fox H.S., Bloom F.E., Elder J.H. Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine triphosphatase. Proc. Natl. Acad. Sci. U.S.A. 92:1995;7480-7484.
44. Lichtenstein D.L., Rushlow K.E., Cook R.F., Raabe M.L., Swardson C.J., Kociba G.J., Issel C.J., Montelaro R.C. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J. Virol. 69:1995;2881-2888.
45. Luciw, P.A., Leung, N.J., 1992. Mechanism of retrovirus replication. In: Levy, J.A. (Ed.), The Retroviridae, Vol. 1, Plenum, New York, pp. 159-298.
46. Maki N., Miyazawa T., Fukasawa M., Hasegawa A., Hayami M., Miki K., Mikami T. Molecular characterization and heterogeneity of feline immunodeficiency virus isolates. Arch. Virol. 123:1992;29-45.
47. Mariani R., Kirchhoff F., Greenough T.C., Sullivan J.L., Desrosiers R.C., Skowronski J. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J. Virol. 70:1996;7752-7764.
48. Michael N.L., George C., D'Arcy L.A., Ehrenberg P.K., Mariani R., Busch M.P., Birx D.L., Schwartz D.H. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J. Virol. 69:1995;4228-4236.
49. Miyazawa T., Mikami T. Biological nature of feline immunodeficiency virus. J. Vet. Med. Sci. 55:1993;519-526.
50. Miyazawa T., Fukasawa M., Hasegawa A., Maki N., Ikuta K., Takahashi E., Hayami M., Mikami T. Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate. J. Virol. 65:1991;1572-1577.
51. Miyazawa T., Kohmoto M., Kawaguchi Y., Tomonaga K., Toyosaki T., Ikuta K., Adachi A., Mikami T. The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes. J. Gen. Virol. 74:1993;1573-1580.
52. Miyazawa T., Inoshima Y., Kohmoto M., Ikeda Y., Mikami T. Growth properties of a feline immunodeficiency virus mutant which lacks an AP-1 binding site in primary peripheral blood mononuclear cells. J. Vet. Med. Sci. 56:1994;869-872.
53. Miyazawa T., Tomonaga K., Kawaguchi Y., Mikami T. The genome of feline immunodeficiency virus. Arch. Virol. 134:1994;221-234.
54. Morikawa S., Lutz H., Aubert A., Bishop D.H.L. Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland. Virus Res. 21:1991;53-63.
55. Novembre F.J., Lewis M.G., Saucier M.M., Yalley-Ogunro J., Brennan T., McKinnon K., Bellah S., McClure H.M. Deletion of the nef gene abrogates the ability of SIVsmmPBj to induce acutely lethal disease in pigtail macaques. AIDS Res. Hum. Retroviruses. 12:1996;727-736.
56. Oberste M.S., Gonda M.A. Conservation of amino acid sequence motifs in lentiviruses vif proteins. Virus Genes. 6:1992;95-102.
57. Oberste M.S., Greenwood J.D., Gonda M.A. Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus. J. Virol. 65:1991;3932-3937.
58. Oliff A., Signorelli K., Collins L. The envelope gene and long terminal repeats sequences contribute to the pathogenic phenotype of helper-independent Friend viruses. J. Virol. 51:1984;788-794.
59. Olmsted R.A., Hirsch V.M., Purcell R.H., Johnson P.R. Nucleotide sequence analysis of feline immunodeficiency virus: genomic and relationship to other lentiviruses. Proc. Natl. Acad. Sci. U.S.A. 86:1989;8088-8092.
60. Pedersen N.C., Ho E.W., Brown M.L., Yamamoto J.K. Isolation of a T lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 235:1987;790-793.
61. Phillips T.R., Talbott R.L., Lamont C., Muir S., Lovelace K., Elder J.H. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol. 64:1990;4605-4613.
62. Phillips T.R., Prospéro-García O., Puaoi D.L., Lerner D.L., Fox H.S., Olmsted R.A., Bloom F.E., Henriksen S.J., Elder J.H. Neurological abnormalities associated with feline immunodeficiency virus infection. J. Gen. Virol. 75:1994;979-987.
63. Phillips T.R., Prospéro-García O., Wheeler D.W., Wagaman P.C., Lerner D.L., Fox H.S., Whalen L.R., Bloom F.E., Elder J.H., Henriksen S.J. Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J. NeuroVirol. 2:1996;388-396.
64. Podell M., Oglesbee M., Mathes L., Krakowka S., Olmsted R., Lafrado L. AIDS-associated encephalopathy with experimental feline immunodeficiency virus infection. J. Acquired Immune Defic. Syndr. 6:1993;758-771.
65. Prospéro-García O., Herold N., Phillips T.R., Elder J.H., Bloom F.E., Henriksen S.J. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12947-12951.
66. Reddy T.R., Kraus G., Yamada O., Looney D.J., Suhasini M., Wong-Staal F. Comparative analyses of human immunodeficiency virus type 1 (HIV-1) and HIV-2 vif mutants. J. Virol. 69:1995;3549-3553.
67. Saltarelli M., Querat G., Konings D.A.M., Vigne R., Clements J.C. Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology. 179:1990;347-364.
68. Shacklett B.L., Luciw P.A. Analysis of the VIF gene of feline immunodeficiency virus. Virology. 204:1994;860-864.
69. Simon J.H.M., Southerling T.E., Peterson J.C., Meyer B.E., Malim M.H. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not non-primate, lentivirus vif gene. J. Virol. 69:1995;4166-4172.
70. Sonigo P., Alizon M., Staskus K., Klatzmann D., Cole S., Danos O., Retzel E., Tiollais P., Haase A., Wain-Hobson S. Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus. Cell. 42:1985;369-382.
71. Sparger E.E., Shacklett B.L., Renshaw-Gegg L., Barry P.A., Pedersen N.C., Elder J.H., Luciw P.A. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. Virology. 187:1992;165-177.
72. Sparger E.E., Beebe A.M., Dua N., Himathongkam S., Elder J.H., Torten M., Higgins J. Infection of cats with molecular cloned and biological isolates of the feline immunodeficiency virus. Virology. 205:1994;546-553.
73. Steagall W.K., Robek M.D., Perry S.T., Fuller F.J., Payne S.L. Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages. Virology. 210:1995;302-313.
74. Stephens R.M., Derse D., Rice N.R. Cloning and characterization of cDNA encoding equine infectious anemia virus Tat and putative Rev proteins. J. Virol. 64:1990;3716-3725.
75. Subbramanian R.A., Cohen E.A. Molecular biology of the human immunodeficiency virus accessory proteins. J. Virol. 68:1994;6831-6835.
76. Talbott R.L., Sparger E.E., Lovelace K.M., Fitch W.M., Pedersen N.C., Luciw P.A., Elder J.H. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 86:1989;5743-5747.
77. Thompson F.J., Elder J., Neil J.C. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat. J. Gen. Virol. 75:1994;545-554.
78. Threadgill D.S., Steagall W.K., Flaherty M.T., Fuller F.J., Perry S.T., Rushlow K.E., Le Grice S.F.J., Payne S.L. Characterization of equine infectious anemia virus dUTPase: growth properties of a dUTPase-deficient mutant. J. Virol. 67:1993;2592-2600.
79. Tomonaga K., Mikami T. Molecular biology of the feline immunodeficiency virus auxiliary genes. J. Gen. Virol. 77:1996;1611-1621.
80. Tomonaga K., Norimine J., Shin Y.-S., Fukasawa M., Miyazawa T., Adachi A., Toyosaki T., Kawaguchi Y., Kai C., Mikami T. Identification of a feline immunodeficiency virus gene which is essential for cell-free virus infectivity. J. Virol. 66:1992;6181-6185.
81. Tomonaga K., Miyazawa T., Sakuragi J., Mori T., Adachi A., Mikami T. The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T cell lines and peripheral blood lymphocytes. J. Virol. 67:1993;5889-5895.
82. Tong-Starksen S., Peterlin B.M. Mechanisms of retroviral transcriptional activation. Semin. Virol. 1:1990;215-227.
83. Tye B.-K., Nyman P.-O., Lehman I.R., Hochhauser S., Weiss B. Transient accumulation of Okazaki fragments as a result of uracil incorporation into nascent DNA. Proc. Natl. Acad. Sci. U.S.A. 74:1977;154-157.
84. Vigne R., Neuveut C., Sire J., Philippon V., Filippi P., Gambarelli D., Clements J.E., Hayman M., Arbuthnott G., Harkiss G. Involvement of viral regulatory gene products in the pathogenesis of lentivirus infections. Ann. New York Acad. Sci. 724:1994;107-124.
85. Vogt M., Haggblom C., Swift S., Haas M. Envelope gene and long terminal repeat determine the different biological properties of Rauscher, Friend, and Moloney mink cell focus-inducing viruses. J. Virol. 55:1985;184-192.
86. Wagaman P.C., Hasselkus-Light C.S., Henson M., Lerner D.L., Phillips T.R., Elder J.H. Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). Virology. 196:1993;451-457.
87. Waters A.K., De Parseval A.P., Lerner D.L., Neil J.C., Thompson F.J., Elder J.H. Influence of ORF2 on host cell tropism of feline immunodeficiency virus. Virology. 215:1996;10-16.
88. Yamamoto J.K., Sparger E., Ho E.W., Andersen P.R., O'Connor T.P., Mandell C.P., Lowenstine L., Munn R., Pedersen N.C. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am. J. Vet. Res. 49:1988;1246-1258.
89. Yokoyama N., Maeda K., Mikami T. Recombinant viral vector vaccines for the veterinary use. J. Vet. Med. Sci. 59:1997;311-322.